GU Podcast (2020): The Expanding Role Of Immune Checkpoint Inhibitors In MIBC And NMIBC
AUAUniversity21 Okt 2020

GU Podcast (2020): The Expanding Role Of Immune Checkpoint Inhibitors In MIBC And NMIBC

The Expanding Role of Immune Checkpoint Inhibitors in MIBC and NMIBC At the conclusion of this activity, participants will be able to: 1. Recognize both historic and newer immunotherapy options in the treatment of bladder cancer. 2. Describe the mechanism of action of immunotherapy regimens. 3. Identify and manage the adverse events related to these agents. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29831

Avsnitt(426)

Immuno - Oncoloy: A New Class Of Drugs

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Okt 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Okt 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Okt 201829min

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Sep 201851min

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School o...

26 Sep 201819min

AUA2018 Take Home Messages - Endourology Stones - Infection Inflammation

AUA2018 Take Home Messages - Endourology Stones - Infection Inflammation

Take home messages from AUA2018 Endourology/Stones: Zeph Okeke, MD Infection/Inflammation: O. Lenaine Westney, MD, FPMRS

20 Sep 201824min

Emerging Treatment Options For Non - Metastatic CRPC Sept 2018

Emerging Treatment Options For Non - Metastatic CRPC Sept 2018

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series...

12 Sep 201832min

Match Or Mismatch Presented by National Medical Student Education Committee

Match Or Mismatch Presented by National Medical Student Education Committee

In a webinar on Feb. 26, moderator Seth Cohen, MD, and panelists Gina Badaloto, MD, Moben Mirza, MD, Jessica Kreshover, MD, and Taylor Kohn (MS4) provide an overview on the application cycle to the Ur...

6 Sep 20181h 29min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
alska-oss
nu-blir-det-historia
sektledare
harrisons-dramatiska-historia
not-fanny-anymore
roda-vita-rosen
johannes-hansen-podcast
allt-du-velat-veta
rss-viktmedicinpodden
sa-in-i-sjalen
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
rss-basta-livet
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-om-vi-ska-vara-arliga
rss-max-tant-med-max-villman
vi-gar-till-historien